Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials

Name: Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials
Creator: Peter Ch'en
Published: 2025-07-21T14:52:18.604Z
Keywords: Merkel Cell Carcinoma, Immunotherapy

Ch'en, Peter; Zhang, Yuzheng; Hippe, Dan

doi:10.17632/wsxgxcwg9h.1

Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials

Published: 21 July 2025| Version 1 | DOI: 10.17632/wsxgxcwg9h.1

Contributors:

Peter Ch'en, Yuzheng Zhang, Dan Hippe

Description

Interactive swimmer plot of patients with immune checkpoint inhibitor-resistant Merkel cell carcinoma (Seattle cohort, data cutoff August 16, 2024).

Files

Institutions

University of Washington

Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials

Description

Files

Institutions

Categories

Licence